University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Microplastics: Small Particles, Big Problem?
- Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease.
- Rutgers Office for Research Using Data to Inform and Improve the Rutgers Research Enterprise.
- Structural Racism and Public Health – AJPH Supplement
- NJACTS Community Engagement Core COVID-19 Resources